Why genetic therapy for a form of blindness is such a large deal

October 12, 2017, 7:32 PM|
On Thursday, an FDA advisory row endorsed capitulation of a therapy that could urge a prophesy of people who have a singular genetic commotion called Leber’s inborn amaurosis (LCA). CBS News medical writer Dr. Tara Narula weighs in.

Short URL: http://hitechnews.org/?p=36225

Posted by on Oct 13 2017. Filed under Health & Medicine. You can follow any responses to this entry through the RSS 2.0. You can leave a response or trackback to this entry

Leave a Reply

Photo Gallery

Log in | Designed by hitechnews